Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.

Source:http://linkedlifedata.com/resource/pubmed/id/10100557

Download in:

View as

General Info

PMID
10100557